Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowth

Bone

Volumn 48, Issue 6, 2011, Pages 1328-1335

  Waters, Katrina M ^a   Jacobs, Jon M ^b   Gritsenko, Marina A ^b   Karin, Norman J ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Dendrites; Gene expression; Lysophosphatidic acid; MLO Y4 osteocyte like cells; Proteomics

Indexed keywords

LYSOPHOSPHATIDIC ACID;

ACTIN FILAMENT; AMINE BIOSYNTHESIS; ARTICLE; BIOSYNTHESIS; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; DENDRITE; DENDRITE OUTGROWTH; DENDRITOGENESIS; DNA REPAIR; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GOLGI COMPLEX; MASS SPECTROMETRY; MEMBRANE BINDING; NERVOUS SYSTEM DEVELOPMENT; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOCYTE; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEOMICS; TRANSCRIPTOMICS; UNFOLDED PROTEIN RESPONSE;

ANIMALS; BASE SEQUENCE; CELL LINE; CHROMATOGRAPHY, ION EXCHANGE; DENDRITES; DNA PRIMERS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LYSOPHOSPHOLIPIDS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBCELLULAR FRACTIONS;

EID: 79955906471     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.02.020     Document Type: Article

References (56)

1. Karagiosis S.A., Chrisler W.B., Bollinger N., Karin N.J. Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation. J Cell Physiol 2009, 219:716-723.
2. 2+ signaling in MC3T3-E1 osteoblastic cells. J Bone Miner Res 2001, 16:2035-2042.
3. Liu R., Farach-Carson M.C., Karin N.J. Effects of sphingosine derivatives on MC3T3-E1 pre-osteoblasts: psychosine elicits release of calcium from intracellular stores. Biochem Biophys Res Commun 1995, 214:676-684.
4. Carpio L.C., Stephan E., Kamer A., Dziak R. Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells. Prostaglandins Leukot Essent Fatty Acids 1999, 61:267-273.
5. Caverzasio J., Palmer G., Suzuki A., Bonjour J.P. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 2000, 15:1697-1706.
6. Dziak R., Yang B.M., Leung B.W., Li S., Marzec N., Margarone J., et al. Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. Prostaglandins Leukot Essent Fatty Acids 2003, 68:239-249.
7. i proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Endocrinology 2001, 142:1098-1106.
8. i proteins and phosphatidylinositol-3 kinase. Endocrinology 2002, 143:4755-4763.
9. Liu Y.B., Kharode Y., Bodine P.V., Yaworsky P.J., Robinson J.A., Billiard J. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4. J Cell Biochem 2010, 109:794-800.
10. Panupinthu N., Rogers J.T., Zhao L., Solano-Flores L.P., Possmayer F., Sims S.M., et al. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol 2008, 181:859-871.
11. Boucharaba A., Serre C.M., Guglielmi J., Bordet J.C., Clezardin P., Peyruchaud O. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc Natl Acad Sci USA 2006, 103:9643-9648.
12. 1 receptors on human osteoblasts. Arch Oral Biol 2008, 53:207-213.
13. Lapierre D.M., Tanabe N., Pereverzev A., Spencer M., Shugg R.P., Dixon S.J., et al. Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction and promote cell survival. J Biol Chem 2010, 285:25792-25801.
14. A1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000, 97:13384-13389.
15. 1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol Cell Neurosci 2003, 24:1170-1179.
16. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993, 291(Pt 3):677-680.
17. Sano T., Baker D., Virag T., Wada A., Yatomi Y., Kobayashi T., et al. Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J Biol Chem 2002, 277:21197-21206.
18. Moolenaar W.H., van Meeteren L.A., Giepmans B.N. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004, 26:870-881.
19. Einhorn T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998, 355(Suppl):S7-S21.
20. Fotos J.S., Patel V.P., Karin N.J., Koh J.T., Temburni M.K., Galileo D.S. Automated time-lapse microscopy and high-resolution tracking of cell migration. Cytotechnology 2006, 51:7-19.
21. Masiello L.M., Fotos J.S., Galileo D.S., Karin N.J. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells. Bone 2006, 39:72-82.
22. Karagiosis S.A., Karin N.J. Lysophosphatidic acid induces osteocyte dendrite outgrowth. Biochem Biophys Res Commun 2007, 357:194-199.
23. Panupinthu N., Zhao L., Possmayer F., Ke H.Z., Sims S.M., Dixon S.J. P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem 2007, 282:3403-3412.
24. Knothe Tate M.L., Adamson J.R., Tami A.E., Bauer T.W. The osteocyte. Int J Biochem Cell Biol 2004, 36:1-8.
25. Lin M.E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010, 91:130-138.
26. Waters K.M., Tan R., Genetos D.C., Verma S., Yellowley C.E., Karin N.J. DNA microarray analysis reveals a role for lysophosphatidic acid in the regulation of anti-inflammatory genes in MC3T3-E1 cells. Bone 2007, 41:833-841.
27. Kato Y., Windle J.J., Koop B.A., Mundy G.R., Bonewald L.F. Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 1997, 12:2014-2023.
28. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
29. Dudoit S., van der Laan M.J., Pollard K.S. Multiple testing. Part I. Single-step procedures for control of general type I error rates. Stat Appl Genet Mol Biol 2004, 3. [Article13].
30. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
31. Shen Y., Zhao R., Belov M.E., Conrads T.P., Anderson G.A., Tang K., et al. Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. Anal Chem 2001, 73:1766-1775.
32. 18O labeling and the accurate mass and time tag approach. Mol Cell Proteomics 2005, 4:700-709.
33. Qian W.J., Jacobs J.M., Camp D.G., Monroe M.E., Moore R.J., Gritsenko M.A., et al. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 2005, 5:572-584.
34. Murshid S.A., Kamioka H., Ishihara Y., Ando R., Sugawara Y., Takano-Yamamoto T. Actin and microtubule cytoskeletons of the processes of 3D-cultured MC3T3-E1 cells and osteocytes. J Bone Miner Metab 2007, 25:151-158.
35. Tanaka-Kamioka K., Kamioka H., Ris H., Lim S.S. Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res 1998, 13:1555-1568.
36. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
37. Cornish J., Grey A., Callon K.E., Naot D., Hill B.L., Lin C.Q., et al. Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1. Biochem Biophys Res Commun 2004, 318:240-246.
38. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998, 393:333-339.
39. Huff T., Muller C.S., Otto A.M., Netzker R., Hannappel E. β-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 2001, 33:205-220.
40. Spiliotis E.T., Nelson W.J. Here come the septins: novel polymers that coordinate intracellular functions and organization. J Cell Sci 2006, 119:4-10.
41. Jacquin C., Koczon-Jaremko B., Aguila H.L., Leng L., Bucala R., Kuchel G.A., et al. Macrophage migration inhibitory factor inhibits osteoclastogenesis. Bone 2009, 45:640-649.
42. Reddy S., Devlin R., Menaa C., Nishimura R., Choi S.J., Dallas M., et al. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol 1998, 177:636-645.
43. Stortelers C., Kerkhoven R., Moolenaar W.H. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling. BMC Genomics 2008, 9:387.
44. 2+-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action. J Biol Chem 1990, 265:12232-12239.
45. Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. J Lipid Res 2009, 50(Suppl):S225-S230.
46. Kim K., Sirota A., Chen Y-h, Jones S.B., Dudek R., Lanford G.W., et al. Dendrite-like process formation and cytoskeletal remodeling regulated by δ-catenin expression. Exp Cell Res 2002, 275:171-184.
47. Kim S., Chiba A. Dendritic guidance. Trends Neurosci 2004, 27:194-202.
48. Le Clainche C., Carlier M.F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008, 88:489-513.
49. Trebaul A., Chan E.K., Midwood K.S. Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans 2007, 35:695-697.
50. Assinder S.J., Stanton J.A., Prasad P.D. Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009, 41:482-486.
51. Morsczeck C., Petersen J., Vollner F., Driemel O., Reichert T., Beck H.C. Proteomic analysis of osteogenic differentiation of dental follicle precursor cells. Electrophoresis 2009, 30:1175-1184.
52. Waters K.M., Pounds J.G., Thrall B.D. Data merging for integrated microarray and proteomic analysis. Brief Funct Genomic Proteomic 2006, 5:261-272.
53. Maelan A.E., Rasmussen T.K., Larsson L.I. Localization of thymosin β10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility. Histochem Cell Biol 2007, 127:109-113.
54. Sun H.Q., Kwiatkowska K., Yin H.L. β-Thymosins are not simple actin monomer buffering proteins. Insights from overexpression studies. J Biol Chem 1996, 271:9223-9230.
55. Fehon R.G., McClatchey A.I., Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010, 11:276-287.
56. Burger E.H., Klein-Nulend J. Mechanotransduction in bone - role of the lacuno-canalicular network. FASEB J 1999, 13(Suppl):S101-S112.